Glimepiride Brown And Burk Uk

Glimepiride Brown And Burk UK is a generic oral medication containing the active ingredient glimepiride, a sulfonylurea class antidiabetic drug. It is supplied in tablet form for prescription use within the European Union market and works by stimulating insulin release from pancreatic beta cells to help lower blood glucose levels in adults with type 2 diabetes mellitus.

Glimepiride Brown And Burk UK is prescribed to improve glycemic control in patients with type 2 diabetes mellitus. It may be used as monotherapy or in combination with other antidiabetic agents when diet and exercise alone are insufficient.

- Adjunct to diet and exercise for type 2 diabetes management. - Combined therapy with metformin or thiazolidinediones when additional glucose lowering is needed. - May be considered when oral hypoglycemic agents are preferred over insulin. - Used in adults who have not achieved target HbA1c with lifestyle changes alone.

Glimepiride Brown And Burk UK can cause a range of side effects, some of which are more frequently reported than others.

Common: - Mild hypoglycemia, especially if meals are missed. - Nausea or abdominal discomfort. - Headache or dizziness. - Weight gain due to increased insulin activity. - Skin rash or mild itching.

Serious: - Severe hypoglycemia leading to confusion or loss of consciousness. - Allergic reactions such as swelling of the face, lips, or throat. - Hepatotoxicity presenting as jaundice or elevated liver enzymes. - Hematologic abnormalities like leukopenia or thrombocytopenia.

Before starting Glimepiride Brown And Burk UK, certain precautions should be considered to ensure safe use.

- Assess renal and hepatic function, as impairment may increase drug exposure. - Monitor blood glucose regularly to avoid hypoglycemia. - Use cautiously in elderly patients who may be more susceptible to low blood sugar. - Review any history of cardiovascular disease, as sulfonylureas can affect cardiac ischemic preconditioning. - Discontinue or adjust dose if pregnant or planning pregnancy, after consulting a healthcare professional. - Avoid use in patients with known hypersensitivity to sulfonylureas.

Glimepiride Brown And Burk UK can interact with several medications, influencing its efficacy or safety profile.

Avoid: - Concurrent use with other sulfonylureas or insulin, which may cause severe hypoglycemia. - Strong CYP2C9 inhibitors (e.g., fluconazole, amiodarone) that increase glimepiride plasma levels. - Disulfiram, which can potentiate hypoglycemic effects.

Use with caution: - Beta‑blockers, which may mask hypoglycemia symptoms. - Thiazide diuretics, which can raise blood glucose. - Corticosteroids or thiazolidinediones, which may counteract glucose‑lowering effects. - Alcohol, as it can enhance hypoglycemia risk.